Valo Health - About the company
Valo Health is a series B company based in Boston (United States), founded in 2019 by David Berry. It operates as an AI-powered platform for drug discovery and development. Valo Health has raised $450M in funding from PSP Investments and Koch Disruptive Technologies, with a current valuation of $*****. The company has 270 active competitors, including 83 funded and 15 that have exited. Its top competitors include companies like Schrodinger, Recursion Pharmaceuticals and Relay Therapeutics.
Company Details
AI-powered platform for drug discovery and development. The company utilizes the Opal Computational Platform, which combines machine learning, tissue biology, and patient data to revolutionize drug discovery and development.
- Website
- www.valohealth.com/
- Registered Address
- Cambridge, Massachusetts
Key Metrics
Founded Year
2019
Location
Boston, United States
Stage
Series B
Total Funding
$450M in 2 rounds
Latest Funding Round
Post Money Valuation
$***** as on Jan 08, 2025
Investors
Ranked
5th among 270 active competitors
Employee Count
211 as on Sep 30, 2026
Investment & Acquisitions
Similar Companies
Legal entities associated with Valo Health
Valo Health is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Valo Health, Inc. CIN: 001t000000WoaIPAAZ , United States, Active | Sep 17, 2020 | - | - | - |
VALO HEALTH INC. CIN: 832616304 , United States, Active | Dec 31, 1999 | - | 105 (As on Dec 31, 2024) | - |
VALO HEALTH, LLC CIN: 83-2616304 , United States, Active | Jun 02, 2019 | - | 117 (As on Dec 31, 2023) | - |
Sign up to download Valo Health's company profile
Valo Health's funding and investors
Valo Health has raised a total funding of $450M over 2 rounds. Its first funding round was on Jan 11, 2021. Its latest funding round was a Series B round on Mar 09, 2021 for $*****. 1 investor participated in its latest round. Valo Health has 9 institutional investors.
Here is the list of recent funding rounds of Valo Health:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 09, 2021 | 7041465 | Series B | 9730748 | 6363836 | 2388293 | 5576492 |
Jan 11, 2021 | 7938361 | Series B | 2707011 | 3571432 |
View details of Valo Health's funding rounds and investors
Valo Health's founders and board of directors
Founder? Claim ProfileThe founders of Valo Health is David Berry.
Here are the details of Valo Health's key team members:
- David Berry: Former Co-Founder of Valo Health.
View details of Valo Health's Founder profiles and Board Members
Valo Health's employee count trend
Valo Health has 211 employees as of Sep 26. Here is Valo Health's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Valo Health's Competitors and alternates
Top competitors of Valo Health include Schrodinger, Recursion Pharmaceuticals and Relay Therapeutics. Here is the list of Top 10 competitors of Valo Health, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Schrodinger 1990, New York City (United States), Acquired | Provider of a web-based simulation and modelling tool | $162M | 74/100 | |
2nd | Recursion Pharmaceuticals 2013, New York (United States), Public | AI-enabled drug discovery and development platform for novel therapeutics | $452M | 72/100 | |
3rd | Relay Therapeutics 2016, Cambridge (United States), Public | Developer of drug discovery platform and study protein motion | $520M | 70/100 | |
4th | Atomwise 2012, San Francisco (United States), Series B | Developer of artificial intelligence platform for small molecule drug discovery | $219M | 67/100 | |
5th | Valo Health 2019, Boston (United States), Series B | AI-powered platform for drug discovery and development | $450M | 69/100 | |
6th | XtalPi 2014, Cambridge (United States), Public | AI-based drug research and development company | $785M | 67/100 | |
7th | Xaira 2023, San Francisco (United States), Series D | AI-enabled platform for drug discovery and development | $1B | 63/100 | |
8th | In Silico 2014, Boston (United States), Public | AI-enabled bioinformatics platform for drug discovery and biomarker development | $510M | 63/100 | |
9th | Tandem AI 2021, New York (United States), Series A | AI-based drug discovery tool for researchers | $82M | 62/100 | |
10th | Healx 2014, Cambridge (United Kingdom), Series C | Provider of AI-powered drug discovery solutions for rare diseases | $115M | 62/100 |
Looking for more details on Valo Health's competitors? Click here to see the top ones
Valo Health's Investments and acquisitions
Valo Health has made 1 investments in companies including Basecamp Research. Valo Health has also acquired 3 companies including TARA Biosystems and Courier Therapeutics.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Aug 09, 2022 | Investments | 2019 | London (United Kingdom) | |
Mar 01, 2022 | Acquisition | 2014 | New York City (United States) | |
Jul 27, 2021 | Acquisition | 2015 | Houston (United States) |
See all acquisitions by Valo Health
Reports related to Valo Health
Here is the latest report on Valo Health's sector:
News related to Valo Health
Media has covered Valo Health for a total of 6 events in the last 1 year, 4 of them have been about people movement and 1 about company updates.
•
Valo Healti Taps Dr.Chris Anagnostopoulos as Chief Kaushal AI OfficerContract Pharma•Apr 14, 2026•Valo Health
•
Valo Health Appoints Chris Anagnostopoulos as Chief Causal AI OfficerBusiness Wire•Apr 14, 2026•Valo Health
•
Valo Health Appoints Karin Conde-Knape as Chief Scientific OfficerBusiness Wire•Feb 03, 2026•Valo Health
•
•
•
Valo Health Receives Grant from Michael J. Fox Foundation for Parkinson's ResearchBusiness Wire•Sep 09, 2025•Valo Health
•
Valo Health and nference Announce Long-term Partnership to Accelerate Human-Centric Drug Discovery and DevelopmentBusiness Wire•Mar 18, 2025•Valo Health, nference
•
Novo Nordisk’s $4.6 Billion Collaboration with Valo HealthGlobal Legal Chronicle•Jan 14, 2025•Cenntro, Valo Health
•
Novo Nordisk and Valo Health Expand AI Partnership for Drug DiscoveryTelecom Talk•Jan 12, 2025•New Nordic, Valo Health
•
Variant Bio Announces Multi-Year Research Partnership with Novo Nordisk to Discover Novel Targets for Metabolic DiseasePR Newswire•Jan 07, 2025•Variant Bio, New Nordic, Valo Health
Are you a Founder ?
FAQs about Valo Health
Explore our recently published companies
- Entrans - Prague based, 2003 founded, Funding Raised company
- Evolvez - New York based, 2019 founded, Unfunded company
- Kognico - New York based, 2003 founded, Unfunded company
- Happy Shark Media - New York based, 2019 founded, Unfunded company
- Spartan Institutional Research - New York based, 1996 founded, Unfunded company
- Ayoki Fabricon - Pune based, 1984 founded, Unfunded company